Allen Wolff's Insider Trades & SAST Disclosures

Allen Wolff's most recent trade in Eterna Therapeutics Inc was a trade of 9,944 Common Stock done at an average price of $2.7 . Disclosure was reported to the exchange on March 24, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Eterna Therapeutics Inc
Allen Wolff Director, Former Director and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.67 per share. 24 Mar 2021 9,944 128,520 - 2.7 26,550 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades